Impact of antenatal screening for Chlamydia and Gonorrhea on pregnancy outcomes in South African women
Open Access
- 21 July 2026
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1) , 1559
Abstract
Background: We evaluated the impact of diagnosing and treating curable STIs during pregnancy on adverse pregnancy outcomes in Cape Town, South Africa. Methods: Eligible women ≥ 15 years, without HIV, attending first antenatal care (ANC) visit before 28 weeks gestation, received diagnostic testing at enrolment and either same-day or follow-up treatment for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) using either on-site GeneXpert or laboratory-based testing with TaqMan qPCR assays. We assessed prevalence of CT/NG, time to treatment and the frequency of poor pregnancy outcomes, individually and combined including pregnancy loss (miscarriage [< 20weeks] or stillbirth [≥ 20weeks]) and perinatal outcomes (low birthweight [< 2500 g], preterm birth [< 37weeks], small for gestational age [< 10th percentile] and neonatal death [< 7days]) among women with or without CT/NG at study enrolment. Logistic regression models evaluated the impact of time to CT/NG treatment on the frequency of individual and combined poor pregnancy outcomes, adjusting for maternal characteristics. Results: Among 1237 pregnant women, the prevalence of CT/NG at first ANC visit was 28% (24% CT, 8% NG). Of those diagnosed with CT/NG ( n = 345), 54% received immediate treatment(< 7 days), while 34% experienced delayed treatment (median time to treatment 28 days (interquartile range: 15–57)) and 12% were untreated during pregnancy. Among women with CT/NG, the frequency of miscarriage (12%) and stillbirth (9%) were highest among women with untreated CT/NG, lower among delayed treatment (4% and 3%), and lowest among immediate treatment (1% and 2%), respectively. Among women with CT/NG at enrolment, poor pregnancy outcome was 28%, 23%, and 29% for immediate, delayed, and no treatment, respectively; 22% among women with no CT/NG at enrolment (overall χ² test, p = 0.05). Untreated CT/NG were associated with increased odds of pregnancy loss (adjusted odds ratio (aOR); 3.27, 95% CI: 1.09–9.80) compared to CT/NG with immediate treatment and compared to no CT/NG at study enrolment (aOR; 5.05, 95% CI: 2.23–11.43). Multivariable analysis showed no significant difference in poor pregnancy outcome by time to CT/NG treatment. Conclusion: Untreated CT/NG during pregnancy increased the odds of experiencing a miscarriage or stillbirth. These findings suggest potential benefits of STI screening using diagnostic tests leading to the timely treatment of curable STIs in pregnancy, and randomized trials are urgently needed to clarify these effects. Clinical trial number: Not applicable.Keywords
Funding Information
- National Institute of Mental Health and Fogarty International (R01MH116771 and K01TW011187)
This publication has 36 references indexed in Scilit:
- The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling studyJournal of the International AIDS Society, 2025
- Point-of-care testing and treatment of sexually transmitted and genital infections to improve birth outcomes in high-burden, low-resource settings (WANTAIM): a pragmatic cluster randomised crossover trial in Papua New GuineaThe Lancet Global Health, 2024
- Global prevalence of Neisseria gonorrhoeae infection in pregnant women: a systematic review and meta-analysisClinical Microbiology and Infection, 2022
- Early pre‐exposure prophylaxis (PrEP) initiation and continuation among pregnant and postpartum women in antenatal care in Cape Town, South AfricaJournal of the International AIDS Society, 2022
- Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development GoalsThe Lancet Child & Adolescent Health, 2022
- Association of Maternal Inflammation During Pregnancy With Birth Outcomes and Infant Growth Among Women With or Without HIV in IndiaJAMA Network Open, 2021
- Diagnosing sexually transmitted infections in resource‐constrained settings: challenges and ways forwardJournal of the International AIDS Society, 2019
- Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort studyThe Lancet Global Health, 2018
- Chlamydia trachomatis and the risk of spontaneous preterm birth, babies who are born small for gestational age, and stillbirth: a population-based cohort studyThe Lancet Infectious Diseases, 2018
- Chlamydia trachomatis and Adverse Pregnancy Outcomes: Meta-analysis of Patients With and Without InfectionMaternal and Child Health Journal, 2018